|
Enveric Biosciences ، Inc. (ENVB) تقييم DCF |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Enveric Biosciences, Inc. (ENVB) Bundle
تبسيط تقييم Enveric Biosciences ، Inc. (ENVB) مع هذه الآلة الحاسبة DCF القابلة للتخصيص! يضم Deal Enveric Biosciences ، Inc. (ENVB) ومدخلات التنبؤ القابلة للتعديل ، يمكنك اختبار السيناريوهات وكشف القيمة العادلة Enveric Biosciences ، Inc. (ENVB) في دقائق.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -6.3 | -64.0 | -19.6 | -16.9 | -9.2 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .1 | .7 | .4 | .4 | .3 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -6.4 | -64.6 | -20.1 | -17.3 | -9.6 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 1.6 | 17.4 | 17.7 | 2.3 | 2.2 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .2 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .7 | .7 | .5 | 1.2 | .5 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | -.9 | -.6 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | -0.0933509 | -0.0933509 | -0.0933509 | -0.0933509 | -0.0933509 | -0.0933509 | -0.0933509 | -0.0933509 | -0.0933509 | -0.0933509 |
| EBITAT | -6.0 | -56.1 | -18.6 | .0 | -9.6 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -5.2 | -56.3 | -18.9 | .9 | -9.7 | -.5 | .0 | .0 | .0 | .0 |
| WACC, % | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | -2 | |||||||||
| Equity Value | 2 | |||||||||
| Diluted Shares Outstanding, MM | 1 | |||||||||
| Equity Value Per Share | 3.48 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real ENVB financials.
- Real-World Data: Historical data and forward-looking estimates (as illustrated in the highlighted cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe how your inputs affect Enveric Biosciences’ valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive Data: Enveric Biosciences’ historical financial reports and projected forecasts.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
- Real-Time Insights: Observe Enveric Biosciences’ intrinsic value update instantly.
- Intuitive Visualizations: Dashboard graphs showcase valuation outcomes and essential metrics.
- Designed for Precision: A robust tool tailored for analysts, investors, and finance professionals.
How It Works
- Download: Get the pre-formatted Excel file containing Enveric Biosciences, Inc.'s (ENVB) financial data.
- Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various projections and instantly compare results.
- Make Decisions: Leverage the valuation findings to inform your investment strategy.
Why Choose Enveric Biosciences, Inc. (ENVB) Calculator?
- Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses tailored for biotech investments.
- Customizable Inputs: Modify the highlighted fields to explore different financial scenarios.
- Detailed Insights: Automatically computes Enveric’s intrinsic value and Net Present Value.
- Preloaded Data: Access to historical and projected data for accurate analysis.
- Professional Quality: Perfect for financial analysts, investors, and biotech consultants.
Who Should Use Enveric Biosciences, Inc. (ENVB)?
- Healthcare Investors: Develop comprehensive valuation models for biotech investments.
- Pharmaceutical Analysts: Assess valuation scenarios to inform strategic decisions in drug development.
- Consultants and Advisors: Deliver precise valuation insights for Enveric Biosciences stock.
- Students and Educators: Utilize real-world biotech data to enhance financial modeling skills.
- Biotech Enthusiasts: Gain insights into how companies like Enveric Biosciences are valued in the healthcare market.
What the Template Contains
- Pre-Filled Data: Includes Enveric Biosciences' historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model with automated calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on tailored inputs.
- Key Financial Ratios: Assess Enveric Biosciences' profitability, efficiency, and leverage.
- Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
- Clear Dashboard: Visual representations and tables summarizing key valuation outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.